hat
Ekip la deja fè etid adisyonèl sou molekil yo ke yo chanje pa efè J147 a sou mitochondriyo ATP synthase-sa ki kapab tèt yo nouvo objektif dwòg. J147 te ranpli tès toksikolojik FDA-a nan bèt yo, epi lajan yo tap chache kòmanse faz 1 J147 esè klinik nan imen ((j147 esè imen).
eng
The team is already performing additional studies on the molecules that are altered by J147’s effect on the mitochondrial ATP synthase—which could themselves be new drug targets. J147 has completed the FDA-required toxicology testing in animals, and funds are being sought to initiate phase 1 J147 clinical trials in humans((j147 human trials).